Quidel Jul 20, 2022 UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies May 27, 2022 In Brief This Week: Quidel, Ortho Clinical Diagnostics, T2 Biosystems, Agilent Technologies, More May 4, 2022 Quidel Q1 Revenues More Than Double on COVID-19 Immunoassay Sales Apr 8, 2022 Quidel Expects up to $1B in Q1 Revenues Feb 17, 2022 Quidel Q4 Revenues Drop 21 Percent, Beat Estimates Feb 17, 2022 Amid Investor Skepticism, Ortho Clinical Diagnostics CEO Lays Out Merits of Acquisition by Quidel Premium Feb 16, 2022 Ortho Clinical Diagnostics Q4 Revenues Rise 1 Percent Jan 13, 2022 JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More Jan 10, 2022 Diagnostics M&A Deals Skyrocket in 2021 as Companies Have COVID-19 Cash to Burn Premium Jan 6, 2022 Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates Dec 1, 2021 360Dx Index Follows Larger Market Trends, Drops 4 Percent in November Nov 30, 2021 Will Rapid Antigen Tests Detect SARS-CoV-2 With Omicron Variant? They Should Premium Nov 4, 2021 Quidel Q3 Revenues Up 7 Percent, Beat Analysts' Estimate Oct 8, 2021 Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate Oct 1, 2021 Broader Markets Weigh Down Dx Stocks, 360Dx Index Falls 4 Percent in September Sep 24, 2021 Mecwins Developing 'Highly Sensitive' Plasmonic Testing Tech for Laboratories, Point of Care Premium Sep 22, 2021 Flu Season Uncertainty Impacts Lab, Vendor Planning Around COVID-19/Flu Combo Testing Premium Sep 20, 2021 US Department of Defense Awards $647M to Procure Rapid Antigen Tests Aug 13, 2021 In Brief This Week: PerkinElmer, Quidel, Abbott, Labcorp, Guardant Health, and More Aug 5, 2021 Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
